Gene Therapy Shows Promise for Age-Related Macular Degeneration

(MedPage Today) -- NEW YORK CITY -- A gene therapy for age-related macular degeneration (AMD) led to extended treatment-free intervals and durable improvement in visual acuity and retinal thickening, a preliminary trial showed. ADVM-022 (ixoberogene...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news